Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomasQing Deng, Michael R. Green, Yuanxin Wang et al.|Nature Medicine|2020Cited by 593
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Elshad Hasanov et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sattva S. Neelapu, Sairah Ahmed et al.|Blood|2021Cited by 213
Survival improvement for patients with metastatic colorectal cancer over twenty yearsFadl A. Zeineddine, John Paul Shen, Mohammad A. Zeineddine et al.|npj Precision Oncology|2023Cited by 172
Large B cell lymphoma microenvironment archetype profilesXubin Li, Michael R. Green, Kartik Singhal et al.|Cancer Cell|2025Cited by 21